TABLE 3.
PCB | All-cause Mortality
|
Breast Cancer-specific Mortality
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Deaths | Censored | HRAdja | 95% CI | PTrendb | Deaths | Censored | HRAdja | 95% CI | PTrendb | |
Wolff Group 1B (Potentially estrogenic, persistent) | ||||||||||
ΣGroup 1B – The 4- or 4′-position is unchlorinated on one phenyl ring | ||||||||||
Tertile 1 | 58 | 150 | 1 | 27 | 181 | 1 | ||||
Tertile 2 | 63 | 146 | 0.98 | (0.67–1.43) | 19 | 190 | 0.72 | (0.39–1.31) | ||
Tertile 3 | 65 | 144 | 0.92 | (0.63–1.35) | 0.93 | 28 | 181 | 1.16 | (0.65–2.05) | 0.22 |
PCB101 – 2,2′,4,5,5′ | ||||||||||
Tertile 1 | 54 | 142 | 1 | 22 | 174 | 1 | ||||
Tertile 2 | 62 | 135 | 1.15 | (0.79–1.66) | 19 | 178 | 0.86 | (0.46–1.60) | ||
Tertile 3 | 58 | 138 | 1.14 | (0.78–1.66) | 0.73 | 29 | 167 | 1.33 | (0.76–2.33) | 0.42 |
PCB174 – 2,2′,3,3′,4,5,6′ | ||||||||||
Tertile 1 | 66 | 142 | 1 | 19 | 189 | 1 | ||||
Tertile 2 | 61 | 148 | 0.95 | (0.70–1.35) | 24 | 185 | 1.27 | (0.69–2.32) | ||
Tertile 3 | 59 | 150 | 1.09 | (0.77–1.56) | 0.90 | 31 | 178 | 1.88 | (1.05–3.36) | 0.12 |
PCB177 – 2,2′,3,3′,4′,5,6 | ||||||||||
Tertile 1 | 59 | 149 | 1 | 18 | 190 | 1 | ||||
Tertile 2 | 62 | 147 | 1.12 | (0.78–1.61) | 30 | 179 | 1.79 | (1.00–3.23) | ||
Tertile 3 | 65 | 144 | 1.18 | (0.82–1.69) | 0.35 | 26 | 183 | 1.71 | (0.93–3.15) | 0.02 |
PCB187 – 2,2′,3,4′,5,5′,6 | ||||||||||
Tertile 1 | 64 | 144 | 1 | 30 | 178 | 1 | ||||
Tertile 2 | 52 | 157 | 0.69 | (0.47–1.00) | 20 | 189 | 0.70 | (0.39–1.25) | ||
Tertile 3 | 70 | 139 | 0.86 | (0.60–1.25) | 0.27 | 24 | 185 | 0.90 | (0.50–1.61) | 0.99 |
PCB199 – 2,2′,3,3′,4′,5,5′,6 | ||||||||||
Tertile 1 | 56 | 152 | 1 | 27 | 181 | 1 | ||||
Tertile 2 | 55 | 154 | 0.88 | (0.60–1.30) | 21 | 188 | 0.88 | (0.49–1.59) | ||
Tertile 3 | 76 | 133 | 1.04 | (0.70–1.56) | 0.70 | 26 | 183 | 1.26 | (0.68–2.32) | 0.29 |
Wolff Group 2A (Potentially anti-estrogenic, persistent) | ||||||||||
ΣGroup 2A – The 4- and 4′-positions are chlorinated on both phenyl rings and one phenyl ring has an unchlorinated 2-position | ||||||||||
Tertile 1 | 63 | 141 | 1 | 29 | 175 | 1 | ||||
Tertile 2 | 57 | 148 | 0.66 | (0.44–0.99) | 24 | 181 | 0.84 | (0.45–1.55) | ||
Tertile 3 | 65 | 139 | 0.60 | (0.39–0.83) | 0.59 | 21 | 183 | 0.72 | (0.37–1.42) | 0.86 |
PCB66 – 2,3′,4,4′ | ||||||||||
Tertile 1 | 48 | 122 | 1 | 16 | 154 | 1 | ||||
Tertile 2 | 57 | 114 | 1.16 | (0.79–1.71) | 27 | 144 | 1.71 | (0.92–3.19) | ||
Tertile 3 | 52 | 119 | 1.10 | (0.74–1.63) | 0.74 | 18 | 153 | 1.10 | (0.55–2.16) | 0.45 |
PCB74 – 2,4,4′,5 | ||||||||||
Tertile 1 | 55 | 149 | 1 | 27 | 177 | 1 | ||||
Tertile 2 | 59 | 146 | 0.83 | (0.56–1.21) | 25 | 180 | 0.93 | (0.53–1.62) | ||
Tertile 3 | 71 | 134 | 0.91 | (0.62–1.34) | 0.57 | 22 | 183 | 0.86 | (0.47–1.57) | 0.76 |
PCB105 – 2,3,3′,4,4′ | ||||||||||
Tertile 1 | 58 | 147 | 1 | 29 | 176 | 1 | ||||
Tertile 2 | 53 | 152 | 0.83 | (0.57–1.22) | 20 | 185 | 0.71 | (0.40–1.26) | ||
Tertile 3 | 74 | 131 | 1.17 | (0.83–1.67) | 0.46 | 25 | 180 | 0.92 | (0.54–1.59) | 0.73 |
PCB118 – 2,3′,4,4′,5 | ||||||||||
Tertile 1 | 62 | 146 | 1 | 26 | 182 | 1 | ||||
Tertile 2 | 55 | 154 | 0.78 | (0.54–1.12) | 24 | 185 | 0.93 | (0.53–1.63) | ||
Tertile 3 | 70 | 139 | 0.63 | (0.43–0.92) | 0.32 | 24 | 185 | 0.96 | (0.51–1.79) | 0.39 |
Wolff Group 2B (Potentially anti-estrogenic, limited dioxin activity, persistent) | ||||||||||
ΣGroup 2B – The 6- and 6′-positions are unchlorinated | ||||||||||
Tertile 1 | 62 | 146 | 1 | 26 | 182 | 1 | ||||
Tertile 2 | 55 | 153 | 0.72 | (0.49–1.05) | 23 | 185 | 0.86 | (0.48–1.55) | ||
Tertile 3 | 70 | 138 | 0.80 | (0.55–1.16) | 0.09 | 25 | 183 | 1.00 | (0.55–1.81) | 0.91 |
PCB138 – 2,2′,3,4,4′,5′ | ||||||||||
Tertile 1 | 57 | 136 | 1 | 27 | 166 | 1 | ||||
Tertile 2 | 57 | 136 | 0.77 | (0.52–1.12) | 18 | 175 | 0.65 | (0.35–1.19) | ||
Tertile 3 | 64 | 129 | 0.79 | (0.54–1.16) | 0.09 | 27 | 166 | 1.07 | (0.60–1.89) | 0.81 |
PCB170 – 2,2′,3,3′,4,4′,5 | ||||||||||
Tertile 1 | 64 | 143 | 1 | 27 | 180 | 1 | ||||
Tertile 2 | 57 | 150 | 0.82 | (0.57–1.19) | 25 | 182 | 0.97 | (0.56–1.70) | ||
Tertile 3 | 65 | 142 | 0.82 | (0.55–1.20) | 0.29 | 22 | 185 | 0.88 | (0.48–1.61) | 0.42 |
Wolff Group 3 (CYP1A1 and CYP2B inducers, biologically persistent) | ||||||||||
ΣGroup 3 – The 2- and 2′- and 4 and 4′-positions are chlorinated and the 5 or 5′-position is chlorinated | ||||||||||
Tertile 1 | 58 | 151 | 1 | 22 | 187 | 1 | ||||
Tertile 2 | 63 | 146 | 0.93 | (0.62–1.39) | 31 | 178 | 1.63 | (0.89–3.00) | ||
Tertile 3 | 66 | 143 | 0.85 | (0.56–1.28) | 0.52 | 21 | 188 | 1.13 | (0.57–2.26) | 0.51 |
PCB99 – 2,2′,4,4′,5 | ||||||||||
Tertile 1 | 46 | 151 | 1 | 18 | 179 | 1 | ||||
Tertile 2 | 59 | 139 | 1.14 | (0.77–1.70) | 27 | 171 | 1.57 | (0.85–2.90) | ||
Tertile 3 | 69 | 129 | 1.11 | (0.75–1.64) | 0.99 | 23 | 175 | 1.39 | (0.73–2.64) | 0.69 |
PCB153 – 2,2′,4,4′,5,5′ | ||||||||||
Tertile 1 | 57 | 150 | 1 | 23 | 184 | 1 | ||||
Tertile 2 | 64 | 144 | 0.96 | (0.66–1.39) | 29 | 179 | 1.39 | (0.79–2.43) | ||
Tertile 3 | 65 | 143 | 0.82 | (0.55–1.21) | 0.38 | 22 | 186 | 1.07 | (0.57–2.00) | 0.57 |
PCB180 – 2,2′,3,4,4′,5,5′ | ||||||||||
Tertile 1 | 59 | 150 | 1 | 26 | 183 | 1 | ||||
Tertile 2 | 57 | 152 | 0.82 | (0.56–1.20) | 22 | 187 | 0.97 | (0.53–1.76) | ||
Tertile 3 | 71 | 138 | 0.93 | (0.62–1.39) | 0.73 | 26 | 183 | 1.29 | (0.69–2.41) | 0.63 |
PCB183 – 2,2′,3,4,4′,5′,6 | ||||||||||
Tertile 1 | 56 | 151 | 1 | 22 | 185 | 1 | ||||
Tertile 2 | 62 | 146 | 1.05 | (0.73–1.52) | 25 | 183 | 1.21 | (0.68–2.16) | ||
Tertile 3 | 66 | 142 | 0.99 | (0.69–1.43) | 0.80 | 26 | 182 | 1.34 | (0.75–2.41) | 0.13 |
PCB203 – 2,2′,3,4,4′,5,5′,6 | ||||||||||
Tertile 1 | 56 | 153 | 1 | 25 | 184 | 1 | ||||
Tertile 2 | 55 | 154 | 1.03 | (0.70–1.52) | 22 | 187 | 1.01 | (0.56–1.83) | ||
Tertile 3 | 76 | 133 | 1.11 | (0.74–1.65) | 0.35 | 27 | 182 | 1.42 | (0.77–2.62) | 0.11 |
Adjusted for age at diagnosis, education, body mass index, and parity/lactation history.
Natural log-transformed.